HAE - Haemonetics Corporation -  [ ]


Ticker Details
Haemonetics Corporation
Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.
IPO Date: January 3, 1994
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $3.38B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.76 | 1.21%
Avg Daily Range (30 D): $1.06 | 1.31%
Avg Daily Range (90 D): $0.95 | 1.48%
Institutional Daily Volume
Avg Daily Volume: .31M
Avg Daily Volume (30 D): .55M
Avg Daily Volume (90 D): .72M
Trade Size
Avg Trade Size (Sh.): 81
Avg Trade Size (Sh.) (30 D): 44
Avg Trade Size (Sh.) (90 D): 46
Institutional Trades
Total Institutional Trades: 9,091
Avg Institutional Trade: $2.75M
Avg Institutional Trade (30 D): $4.56M
Avg Institutional Trade (90 D): $3.81M
Avg Institutional Trade Volume: .04M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $3.9M
Avg Closing Trade (30 D): $10.09M
Avg Closing Trade (90 D): $8.41M
Avg Closing Volume: 55.02K
 
News
Jan 9, 2026 @ 1:16 PM
Haemonetics Expands Heart Surgery Arsenal With Viv...
Source: Akanksha Bakshi
Aug 14, 2025 @ 2:58 PM
Patient Blood Management Market Growth Analysis Re...
Source: Researchandmarkets.Com
Aug 7, 2025 @ 10:33 AM
Haemonetics (HAE) Q1 Revenue Falls 4%
Source: Jesterai
Feb 28, 2025 @ 6:00 PM
Global Blood Bank Market to Register Immense Growt...
Source: Delveinsight
Nov 21, 2024 @ 6:30 AM
[Latest] Global Apheresis Equipment Market Size/Sh...
Source: Custom Market Insights
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $3.43 $.81 $.71
Diluted EPS $3.42 $.81 $.7
Revenue $1.33B $327.32M $321.39M
Gross Profit $773.59M $194.74M $192.24M
Net Income / Loss $168.19M $38.68M $34.03M
Operating Income / Loss $242.73M $58.49M $53.87M
Cost of Revenue $554.27M $132.57M $129.15M
Net Cash Flow $-2.86M $3.53M $-13.87M
PE Ratio 20.59    
Splits
Dec 03, 2012 2:1